Psychedelic therapies are returning to clinical research and may soon re-enter medical care for mental illness, but substantial work remains before they are ready for widespread use. When combined with psychotherapy, substances such as psilocybin (from 'magic mushrooms') and MDMA (from 'ecstasy') show potential for treating mental health conditions.